» Articles » PMID: 16339933

Garlic Blocks Quorum Sensing and Promotes Rapid Clearing of Pulmonary Pseudomonas Aeruginosa Infections

Overview
Specialty Microbiology
Date 2005 Dec 13
PMID 16339933
Citations 129
Authors
Affiliations
Soon will be listed here.
Abstract

The opportunistic human pathogen Pseudomonas aeruginosa is the predominant micro-organism of chronic lung infections in cystic fibrosis patients. P. aeruginosa colonizes the lungs by forming biofilm microcolonies throughout the lung. Quorum sensing (QS) renders the biofilm bacteria highly tolerant to otherwise lethal doses of antibiotics, and protects against the bactericidal activity of polymorphonuclear leukocytes (PMNs). It has been previously demonstrated that QS is inhibited by garlic extract. In this study, the synergistic effects of garlic and tobramycin, and PMNs activities have been evaluated. P. aeruginosa was grown in vitro in continuous-culture once-through flow chambers with and without garlic extract. The garlic-treated biofilms were susceptible to both tobramycin and PMN grazing. Furthermore, the PMNs showed an increase in respiratory burst activation, when incubated with the garlic-treated biofilm. Garlic extract was administered as treatment for a mouse pulmonary infection model. Mice were treated with garlic extract or placebo for 7 days, with the initial 2 days being prophylactic before P. aeruginosa was instilled in the left lung of the mice. Bacteriology, mortality, histopathology and cytokine production were used as indicators. The garlic treatment initially provoked a higher degree of inflammation, and significantly improved clearing of the infecting bacteria. The results indicate that a QS-inhibitory extract of garlic renders P. aeruginosa sensitive to tobramycin, respiratory burst and phagocytosis by PMNs, as well as leading to an improved outcome of pulmonary infections.

Citing Articles

Innovative application of ceftriaxone as a quorum sensing inhibitor in Pseudomonas aeruginosa.

Naga N, El-Badan D, Mabrouk M, Rateb H, Ghanem K, Shaaban M Sci Rep. 2025; 15(1):5022.

PMID: 39934154 PMC: 11814147. DOI: 10.1038/s41598-025-87609-0.


The Bacterial Biofilms: Formation, Impacts, and Possible Management Targets in the Healthcare System.

Omwenga E, Awuor S Can J Infect Dis Med Microbiol. 2024; 2024:1542576.

PMID: 39717533 PMC: 11666319. DOI: 10.1155/cjid/1542576.


Contribution of the infection ecosystem and biogeography to antibiotic failure in vivo.

Nazeer R, Askenasy I, Swain J, Welch M NPJ Antimicrob Resist. 2024; 2(1):45.

PMID: 39649078 PMC: 11618093. DOI: 10.1038/s44259-024-00063-2.


Advancing Antibiotic-Resistant Microbe Combat: Nanocarrier-Based Systems in Combination Therapy Targeting Quorum Sensing.

Rajkhowa S, Hussain S, Agarwal M, Zaheen A, Al-Hussain S, Zaki M Pharmaceutics. 2024; 16(9).

PMID: 39339197 PMC: 11434747. DOI: 10.3390/pharmaceutics16091160.


Biofilm Production and Its Implications in Pediatrics.

Principi N, Esposito S Microorganisms. 2024; 12(8).

PMID: 39203365 PMC: 11356046. DOI: 10.3390/microorganisms12081522.